140 related articles for article (PubMed ID: 21787315)
41. Amyloid-β peptides are generated in mitochondria-associated endoplasmic reticulum membranes.
Schreiner B; Hedskog L; Wiehager B; Ankarcrona M
J Alzheimers Dis; 2015; 43(2):369-74. PubMed ID: 25096627
[TBL] [Abstract][Full Text] [Related]
42. Nitric oxide links mitochondrial fission to Alzheimer's disease.
Westermann B
Sci Signal; 2009 May; 2(69):pe29. PubMed ID: 19417214
[TBL] [Abstract][Full Text] [Related]
43. Mitochondria and Alzheimer's disease: amyloid-beta peptide uptake and degradation by the presequence protease, hPreP.
Alikhani N; Ankarcrona M; Glaser E
J Bioenerg Biomembr; 2009 Oct; 41(5):447-51. PubMed ID: 19798557
[TBL] [Abstract][Full Text] [Related]
44. Caprospinol: discovery of a steroid drug candidate to treat Alzheimer's disease based on 22R-hydroxycholesterol structure and properties.
Papadopoulos V; Lecanu L
J Neuroendocrinol; 2012 Jan; 24(1):93-101. PubMed ID: 21623958
[TBL] [Abstract][Full Text] [Related]
45. Stable expression of a novel fusion peptide of thioredoxin-1 and ABAD-inhibiting peptide protects PC12 cells from intracellular amyloid-beta.
Yang X; Yang Y; Wu J; Zhu J
J Mol Neurosci; 2007; 33(2):180-8. PubMed ID: 17917077
[TBL] [Abstract][Full Text] [Related]
46. Alzheimer's disease: inside, outside, upside down.
Yan SD; Schmidt AM; Stern D
Biochem Soc Symp; 2001; (67):15-22. PubMed ID: 11447831
[TBL] [Abstract][Full Text] [Related]
47. Novel Benzothiazole-based Ureas as 17β-HSD10 Inhibitors, A Potential Alzheimer's Disease Treatment.
Aitken L; Benek O; McKelvie BE; Hughes RE; Hroch L; Schmidt M; Major LL; Vinklarova L; Kuca K; Smith TK; Musilek K; Gunn-Moore FJ
Molecules; 2019 Jul; 24(15):. PubMed ID: 31362457
[No Abstract] [Full Text] [Related]
48. The organellar peptidasome, PreP: a journey from Arabidopsis to Alzheimer's disease.
Glaser E; Alikhani N
Biochim Biophys Acta; 2010; 1797(6-7):1076-80. PubMed ID: 20036633
[TBL] [Abstract][Full Text] [Related]
49. Identification of amyloid-beta 1-42 binding protein fragments by screening of a human brain cDNA library.
Munguia ME; Govezensky T; Martinez R; Manoutcharian K; Gevorkian G
Neurosci Lett; 2006 Apr 10-17; 397(1-2):79-82. PubMed ID: 16384638
[TBL] [Abstract][Full Text] [Related]
50. Structure-based design and synthesis of benzothiazole phosphonate analogues with inhibitors of human ABAD-Aβ for treatment of Alzheimer's disease.
Valasani KR; Hu G; Chaney MO; Yan SS
Chem Biol Drug Des; 2013 Feb; 81(2):238-49. PubMed ID: 23039767
[TBL] [Abstract][Full Text] [Related]
51. In Vitro Assay Development and HTS of Small-Molecule Human ABAD/17β-HSD10 Inhibitors as Therapeutics in Alzheimer's Disease.
Aitken L; Baillie G; Pannifer A; Morrison A; Jones PS; Smith TK; McElroy SP; Gunn-Moore FJ
SLAS Discov; 2017 Jul; 22(6):676-685. PubMed ID: 28314118
[TBL] [Abstract][Full Text] [Related]
52. Effect of gender on mitochondrial toxicity of Alzheimer's Abeta peptide.
Viña J; Lloret A; Vallés SL; Borrás C; Badía MC; Pallardó FV; Sastre J; Alonso MD
Antioxid Redox Signal; 2007 Oct; 9(10):1677-90. PubMed ID: 17822363
[TBL] [Abstract][Full Text] [Related]
53. Mitochondria, cholesterol and amyloid beta peptide: a dangerous trio in Alzheimer disease.
Colell A; Fernández A; Fernández-Checa JC
J Bioenerg Biomembr; 2009 Oct; 41(5):417-23. PubMed ID: 19784764
[TBL] [Abstract][Full Text] [Related]
54. The amyloid-β-SDR5C1(ABAD) interaction does not mediate a specific inhibition of mitochondrial RNase P.
Vilardo E; Rossmanith W
PLoS One; 2013; 8(6):e65609. PubMed ID: 23755257
[TBL] [Abstract][Full Text] [Related]
55. Infantile Neurodegeneration Results from Mutants of 17β-Hydroxysteroid Dehydrogenase Type 10 Rather Than Aβ-Binding Alcohol Dehydrogenase.
He XY; Dobkin C; Brown WT; Yang SY
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239833
[TBL] [Abstract][Full Text] [Related]
56. Endophilin I expression is increased in the brains of Alzheimer disease patients.
Ren Y; Xu HW; Davey F; Taylor M; Aiton J; Coote P; Fang F; Yao J; Chen D; Chen JX; Yan SD; Gunn-Moore FJ
J Biol Chem; 2008 Feb; 283(9):5685-91. PubMed ID: 18167351
[TBL] [Abstract][Full Text] [Related]
57. Mitochondrial accumulation of amyloid β (Aβ) peptides requires TOMM22 as a main Aβ receptor in yeast.
Hu W; Wang Z; Zheng H
J Biol Chem; 2018 Aug; 293(33):12681-12689. PubMed ID: 29925587
[TBL] [Abstract][Full Text] [Related]
58. An intracellular protein that binds amyloid-beta peptide and mediates neurotoxicity in Alzheimer's disease.
Yan SD; Fu J; Soto C; Chen X; Zhu H; Al-Mohanna F; Collison K; Zhu A; Stern E; Saido T; Tohyama M; Ogawa S; Roher A; Stern D
Nature; 1997 Oct; 389(6652):689-95. PubMed ID: 9338779
[TBL] [Abstract][Full Text] [Related]
59. Amyloid-beta-induced mitochondrial dysfunction.
Chen JX; Yan SD
J Alzheimers Dis; 2007 Sep; 12(2):177-84. PubMed ID: 17917162
[TBL] [Abstract][Full Text] [Related]
60. Role of ERAB/L-3-hydroxyacyl-coenzyme A dehydrogenase type II activity in Abeta-induced cytotoxicity.
Yan SD; Shi Y; Zhu A; Fu J; Zhu H; Zhu Y; Gibson L; Stern E; Collison K; Al-Mohanna F; Ogawa S; Roher A; Clarke SG; Stern DM
J Biol Chem; 1999 Jan; 274(4):2145-56. PubMed ID: 9890977
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
